发明名称 |
Hemojuvelin fusion proteins and uses thereof |
摘要 |
The present invention provides a hemojuvelin (HJV) fusion protein (e.g., a human HJV.Fc) protein, polynucleotides and vectors encoding such proteins, and methods for making such proteins. Also provided are methods for treating iron-related disorders which include administration of a HJV fusion protein to a patient in need thereof. |
申请公布号 |
US8895002(B2) |
申请公布日期 |
2014.11.25 |
申请号 |
US200812595423 |
申请日期 |
2008.04.09 |
申请人 |
The General Hospital Corporation |
发明人 |
Lin Herbert Y.;Babitt Jodie;Woolf Clifford J.;Samad Tarek A. |
分类号 |
A61K38/18;C07K14/475;C12N15/62;C12N15/63;C07H21/04;C07K14/71 |
主分类号 |
A61K38/18 |
代理机构 |
Lathrop & Gage LLP |
代理人 |
Lathrop & Gage LLP |
主权项 |
1. A fusion protein comprising:
(a) a hemojuvelin (HJV) polypeptide or fragment thereof, wherein said polypeptide or fragment thereof has at least 95% amino acid sequence identity to a portion of the HJV protein of SEQ ID NOs: 2, 3 or 4 and is at least 50 amino acids in length; and (b) a first fusion partner, wherein said first fusion partner is conjugated to said HJV polypeptide or fragment thereof, wherein said first fusion partner is an IgG1 Fc; and (c) a second fusion partner. |
地址 |
Boston MA US |